AU2006245282A1 - Compositions and methods for skin care - Google Patents

Compositions and methods for skin care Download PDF

Info

Publication number
AU2006245282A1
AU2006245282A1 AU2006245282A AU2006245282A AU2006245282A1 AU 2006245282 A1 AU2006245282 A1 AU 2006245282A1 AU 2006245282 A AU2006245282 A AU 2006245282A AU 2006245282 A AU2006245282 A AU 2006245282A AU 2006245282 A1 AU2006245282 A1 AU 2006245282A1
Authority
AU
Australia
Prior art keywords
vitamin
nicotinamide
cadpr
skin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006245282A
Other languages
English (en)
Inventor
Olga Bloch
Zeev Even-Chen
Avikam Harel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Dermipsor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermipsor Ltd filed Critical Dermipsor Ltd
Publication of AU2006245282A1 publication Critical patent/AU2006245282A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU2006245282A 2005-05-10 2006-05-10 Compositions and methods for skin care Abandoned AU2006245282A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67932905P 2005-05-10 2005-05-10
US60/679,329 2005-05-10
PCT/IL2006/000552 WO2006120681A2 (en) 2005-05-10 2006-05-10 Compositions and methods for skin care

Publications (1)

Publication Number Publication Date
AU2006245282A1 true AU2006245282A1 (en) 2006-11-16

Family

ID=37396969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006245282A Abandoned AU2006245282A1 (en) 2005-05-10 2006-05-10 Compositions and methods for skin care

Country Status (7)

Country Link
US (1) US8034788B2 (cg-RX-API-DMAC10.html)
EP (1) EP1879449A4 (cg-RX-API-DMAC10.html)
JP (1) JP2008540513A (cg-RX-API-DMAC10.html)
CN (1) CN101217868A (cg-RX-API-DMAC10.html)
AU (1) AU2006245282A1 (cg-RX-API-DMAC10.html)
CA (1) CA2608021A1 (cg-RX-API-DMAC10.html)
WO (1) WO2006120681A2 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
JP2008540514A (ja) * 2005-05-10 2008-11-20 ダーミプソル リミテッド 過剰増殖表皮疾患の治療用組成物及び方法
WO2008131256A1 (en) * 2007-04-19 2008-10-30 Trinity Laboratories Inc. Improved treatments for premature ejaculation in humans
US20110123481A1 (en) * 2007-08-16 2011-05-26 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
FR2936421B1 (fr) * 2008-09-29 2011-02-11 Bouill Mariya Le Produit de beaute et de soin pour faire disparaitre les rides du visage, empecher leur apparition et maintenir la tonicite de la peau
RU2397770C1 (ru) * 2008-12-30 2010-08-27 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Поливитаминная мазь для смягчения, питания и заживления кожи и способ ее получения
MX366076B (es) * 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
RU2560677C2 (ru) * 2009-12-22 2015-08-20 Лео Фарма А/С Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
WO2011087525A1 (en) * 2010-01-17 2011-07-21 The Procter & Gamble Company Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
KR102114892B1 (ko) * 2016-01-11 2020-05-26 더 프록터 앤드 갬블 캄파니 피부 상태의 치료 방법 및 그를 위한 조성물
ES2859777T3 (es) * 2017-02-06 2021-10-04 3Skin As Composición de filtro solar
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
CN114126623A (zh) * 2019-05-17 2022-03-01 宾夕法尼亚大学董事会 治疗肥胖和/或皮肤紊乱的方法和组合物
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
CN118384058A (zh) * 2024-04-08 2024-07-26 云南贝泰妮生物科技集团股份有限公司 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120722A (en) 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
WO1987000834A1 (en) 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
DE69213844T2 (de) 1991-07-05 1997-04-10 Duphar Int Res Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür
DE4141746A1 (de) 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
US5237629A (en) * 1992-03-19 1993-08-17 The United States Of America As Represented By The United States Department Of Energy Digitally controlled distributed phase shifter
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
US5747479A (en) 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
EP0900185B1 (en) 1996-05-02 2001-03-14 Duphar International Research B.V Vitamin d analogs and methods of preparing these compounds
US5811414A (en) 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6262041B1 (en) 1998-04-06 2001-07-17 Bertek Pharmaceuticals, Inc. Use of vitamin D analogs to treat conditions related to increased oxidative stress
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
CN1173703C (zh) 1999-04-23 2004-11-03 里奥药物制品有限公司 药物组合物
FR2801305B1 (fr) 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
IL133976A (en) 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders
CA2492248A1 (en) * 2002-07-11 2004-01-22 Avikam Harel Composition and methods for the treatment of skin disorders

Also Published As

Publication number Publication date
US8034788B2 (en) 2011-10-11
WO2006120681A2 (en) 2006-11-16
WO2006120681A3 (en) 2007-01-25
EP1879449A2 (en) 2008-01-23
US20080312181A1 (en) 2008-12-18
CN101217868A (zh) 2008-07-09
EP1879449A4 (en) 2009-12-16
CA2608021A1 (en) 2006-11-16
JP2008540513A (ja) 2008-11-20

Similar Documents

Publication Publication Date Title
US8034788B2 (en) Composition and methods for skin care
US6352698B1 (en) Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
EP0907351B2 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
DE69927507T2 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
JP3802034B2 (ja) ベツリン酸を含む化粧品組成物
DE69321479T2 (de) Retinol enthaltende kosmetische zusammensetzung
US6623728B2 (en) Cosmetic skin care compositions and containing gum mastic
RU2562140C2 (ru) Композиция и способ для лечения признаков старения кожи
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
EP1000613A2 (en) Composition against the ageing and its use
HK1211866A1 (en) Antioxidant compositions and methods of using the same
CA2608023A1 (en) Compositions comprising calcipotriol and nicotinamide for treating hyperproliferative epidermal diseases
EP1565189A1 (en) Anti-aging skin care composition and uses thereof
US11110117B2 (en) Skin preparation composition for external use containing complex hyaluronic acid
PL196079B1 (pl) Kompozycja kosmetyczna
DE60124307T2 (de) Hautpflegemittel enthaltend retinoide und phytoöstrogene in einem doppelkammer-behältnis
EP2133066A1 (en) Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
US20140037561A1 (en) Composition and methods of enhanced skin cell turnover
IL187237A (en) Preparations containing calcipotriol and nicotinamide for use in skin care
EP1267813A2 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
US6994864B2 (en) Composition containing 7-hydroxy DHEA and/or 7-keto DHEA and at least a carotenoid
US20240423897A1 (en) Longevity serum
US20250049685A1 (en) Collagen lotion formulations and methods of use thereof
US20250049686A1 (en) Collagen serum formulations and methods of use thereof
CN119345166A (zh) 紫萁酮促进胶原蛋白和/或弹性蛋白生成的应用

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD CO-INVENTOR BLOCH, OLGA

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application